Please login to the form below

Not currently logged in
Email:
Password:

chronic diseases

This page shows the latest chronic diseases news and features for those working in and with pharma, biotech and healthcare.

'Femtech' poised to explode, with applications set to trigger healthcare disruption

'Femtech' poised to explode, with applications set to trigger healthcare disruption

Such femtech applications target reproductive, maternal and general women’s health and wellness, including mental health issues, elderly care, and chronic and communicable diseases.

Latest news

More from news
Approximately 6 fully matching, plus 167 partially matching documents found.

Latest Intelligence

  • No incentive for a cure No incentive for a cure

    Type 1 diabetes, heart failure, HIV - all examples of diseases that have transitioned from fatal conditions to chronic diseases, thanks to the progress in modern medicine. ... The question is, are incremental improvements sustainable in the long-term,

  • The rise of real-world evidence The rise of real-world evidence

    Yet, RWE originally established itself in chronic diseases. “It can help differentiate you in a crowded space or, for more complex, chronic diseases, it can show that the benefits seen in

  • Significant figures Significant figures

    lung diseases demonstrated complete eradication compared to only 9% of patients on placebo. ... NTM is a rare progressive, destructive infection that’s normally found in addition to pulmonary diseases such as chronic obstructive pulmonary disease (COPD)

  • The tipping point The tipping point

    In chronic diseases such as rheumatoid arthritis and inflammatory bowel disease, there are significantly greater savings from switching patients compared with initiating biosimilars in naïve patients alone.

  • Asthma: beyond the blue and the brown Asthma: beyond the blue and the brown

    Combine asthma with other respiratory diseases, including chronic obstructive pulmonary disease (COPD), and it contributes to more than 4 million deaths every single year, a stagnated figure that has seen no ... To make progress in chronic airway diseases

More from intelligence
Approximately 2 fully matching, plus 37 partially matching documents found.

Latest appointments

  • Kymab appoints its first chief medical officer Kymab appoints its first chief medical officer

    She has over 20 years of experience biomedical research and has focused on pathogenic mechanisms, underlying chronic inflammatory diseases and the interface between autoimmunity and cancer.

  • Dr Li Zhou joins TxCell as cell engineering VP Dr Li Zhou joins TxCell as cell engineering VP

    Dr Zhou will lead the team's discovery and engineering activities on Chimeric Antigen Receptor in Treg cells ( CAR-Treg) for immunotherapy of severe chronic autoimmune and inflammatory diseases and organ

  • Sanofi’s US pharma head joins Synta as CEO Sanofi’s US pharma head joins Synta as CEO

    She now leads an emerging US-based biopharma focused on the development of small molecule drugs to treat patients with severe medical conditions, including cancer and chronic inflammatory diseases. “

  • Medgenics confirms appointment of Dr Marvin Garovoy

    The company's Biopump uses a patient's own tissue to continuously produce and deliver their protein therapy and, potentially, has applications in a range of chronic diseases, including diabetes, multiple

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re an independent brand and marketing agency that believes our DNA is a little different from others. * A respectful,...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics